[Palliative treatment of esophageal carcinoma: chemotherapy and palliative care]

scientific article published on 01 May 2005

[Palliative treatment of esophageal carcinoma: chemotherapy and palliative care] is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0399-8320(05)82128-1
P698PubMed publication ID15980750

P2093author name stringEveline Boucher
Florence Trivin
Jean-Luc Raoul
Claudia Lefeuvre
Elisabeth Le Prise
P2860cites workSalvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagusQ77655399
Combined radiochemotherapy for postoperative recurrence of oesophageal cancerQ34408399
Relapse patterns after chemo-radiation for carcinoma of the oesophagus.Q35151818
The pattern of recurrence of adenocarcinoma of the oesophago-gastric junctionQ36644282
Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancerQ36648325
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalQ39405901
Radiation therapy for loco-regionally recurrent esophageal cancer after surgeryQ39413262
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancerQ39436075
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative GroupQ42557591
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapyQ43515558
Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagusQ43988072
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialQ44017893
Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancerQ44028630
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinomaQ44383143
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancerQ44434920
Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.Q44691624
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup studyQ71975350
Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent diseaseQ73169047
EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancerQ73600851
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerQ73707393
Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomyQ75401601
Prognosis of patients with advanced carcinoma of the esophagus with complete response to chemotherapy and/or radiation therapy: a questionnaire survey in JapanQ77164632
The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancerQ77424619
P433issue5
P921main subjectesophageal carcinomaQ18553999
P304page(s)557-560
P577publication date2005-05-01
P1433published inGastroenterologie Clinique et BiologiqueQ15756157
P1476title[Palliative treatment of esophageal carcinoma: chemotherapy and palliative care]
P478volume29

Search more.